Loading...
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon
Malaria is still one of the major public health threats in sub-Saharan Africa. An effective vaccine could be a sustainable control measure that can be integrated into existing health infrastructures. The malaria vaccine candidate GMZ2 is a recombinant fusion protein of conserved parts of Plasmodium...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3776947/ https://ncbi.nlm.nih.gov/pubmed/20696154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2010.07.085 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|